Medication without harm WHO Global Patient Safety Challenge Discussion paper for public consultation

Consultation on this discussion paper closed 5 July 2019.

Downloads

Medication without harm WHO Global Patient Safety Challenge Discussion paper for public consultation

Consultation Draft Feedback Form

Accessibility - We aim to provide documents in an accessible format. If you're having problems using a document with your accessibility tools, please contact us for help.

Copyright - Unless stated otherwise, materials provided are covered by a Creative Commons Attribution-Non-Commercial-Share Alike (BY-NC-ND) 4.0 International License.

Description

In March 2017, the World Health Organization (WHO) launched the third Global Patient Safety Challenge (Challenge) with the theme of medication without harm. The goal of the Challenge is to gain worldwide commitment and action to reduce severe, avoidable medication-related harm by 50% in the next five years.

The Australian Government made a commitment to participate in the Challenge, and the Commission is tasked with developing a national response.

The three focus areas of the Challenge are high-risk situations (high-risk medicines), polypharmacy and transitions of care. The high-risk medicines are anti-psychotics, insulin, opioids, heparin and anti-coagulants. More information on the focus areas can be found in the booklet from the WHO, Medication without harm 2017. To download the document visit: https://www.who.int/patientsafety/medication-safety/en/External link

Public consultation on this response closed Friday 5 July 2019.

Publication year
2019
Resource type
Publication, report or update